Yuliya D. Lukyanchik

Yuliya D. Lukyanchik

Auto-generated profile, based on publicly available information

Yuliya D. Lukyanchik

Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YLYuliya D. Lukyanchik
Yuliya D. Lukyanchik
TCTatyana V. Chernysheva
Tatyana V. Chernysheva
EMElena I. Malinina
Elena I. Malinina
LGLyudmila I. Gapon
Lyudmila I. Gapon
TPTatyana I. Petelina
Tatyana I. Petelina
ЗВЗуева Екатерина Владимировна
Зуева Екатерина Владимировна
Background: Active athletic activity can occasionally trigger the development of cardiovascular diseases, especially in highly dynamic sports. Athletes who perform their training in cold climatic conditions are at risk of exhaustion of the functional reserve of the body and the sports-associated overstrain. Aim: To determine the characteristics of heart rate variability (HRV) and cardiac biomarkers in young hockey and football players in the Far North, to search for predictors of pathological myocardial remodeling. Methods: This was an observational cross-sectional study in 160 boys aged 12 to 17 with health groups II to III performed in the Children's Health Center of the Novourengoy Central Regional Hospital in Spring 2022. We performed a standard electrocardiography (ECG) and 24-hour ECG monitoring, echocardiography (EchoCG), and blood sampling for markers of myocardial damage, endothelial dysfunction, and proteolysis. The study group consisted of 86 children involved in hockey and football, and the control group consisted of 74 teenagers not going in for active sports. Results: The median values of the primary waves and intervals on the standard ECG were within the normal range in both groups. The 24-hour ECG monitoring showed significant differences between the study groups for average heart rate (84 [78; 91] vs. 93 [83; 100], p 0.001) and maximal heart rate (150 [128; 159] vs. 159 [147; 184], p = 0.001). The proportion of children with reduced HRV in the control group was significantly higher than in the athlete group (64.2% vs. 36.4%). Median levels of the myocardial damage markers were within the reference ranges in all study children, with lactate dehydrogenase (p = 0.034), aspartate aminotransferase (p = 0.001), and troponin I (p = 0.011) levels being significantly lower in the athlete group. As for the EchoCG parameters, there was a 1.2-fold increase in the left ventricular mass index and the right ventricular systolic area in the athletes compared to the control group (p 0.001). According to the ROC analysis, the cut-off value of matrix metalloproteinase 2 predictive for the high risk of myocardial remodeling in the athletes was 337.49 ng/mL, with sensitivity of 75% and specificity of 87.2%. Conclusion: The matrix metalloproteinase 2 levels above 337.49 ng/mL and low HRV may be considered as risk factors for myocardial remodeling in athletes with borderline electrocardiographic and echocardiographic parameters.

2 March 2023 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
YLYu. D. Lukiyanchik
Yu. D. Lukiyanchik
EME. I. Malinina
E. I. Malinina
TCT. V. Chernysheva
T. V. Chernysheva
LGL. I. Gapon
L. I. Gapon
TPT. I. Petelina
T. I. Petelina
ЮЛЮ. Д. Лукьянчик
Ю. Д. Лукьянчик
Myocardial remodeling is well-known to be both an adaptive option under certain conditions of life (sports, pregnancy, etc.), and the result of cardiovascular pathology. The study of the features of cardiac remodeling includes the involvement of cardiomyocytes in the process by the level of troponins, creatine phosphokinase, and its cardiac isoform as markers of ischemia and necrosis. Also, neurohormonal rearrangement is evaluated using a natriuretic peptide, and endothelial dysfunction is determined using a C–reactive protein. The level of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) reflects the degree of the proteolytic activity and collagen fibers’ degradation. However, there are no clear biochemical markers of “adaptive heart” and pathological changes in different age periods, in the climatic environment, various types and severity of sports loads, especially when evaluating matrix metalloproteinases and their tissue inhibitors. The primary task in determining the criteria for pathological remodeling of the myocardium becomes the definition of normative indicators.The aim of the study was to determine the reference values of the main biochemical markers of cardiac remodeling in healthy adolescents living in the Far North. The levels of troponin I, creatine phosphokinase-MV, aspartate aminotransferase did not exceed the generally accepted standard values. There were correlations between lactate dehydrogenase, aspartate aminotransferase, and mass-growth indicators of adolescents. Markers of extracellular matrix degradation (MMP-9, TIMP-1 and TIMP-4, MMP-9/ TIMP-1) differed from the data available in the published studies, which is probably due to the influence of tissue hypoxia associated with the climatic living conditions and the age in children of the study group.